Search the Newsreel

CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Tops Revenue Estimates

CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $1.1. This compares to a loss of $1.29 per share a year ago. These figures are adjusted for non-recurring items. This …

Crispr Therapeutics earnings beat by $0.26, revenue topped estimates

Crispr Therapeutics reported a second-quarter EPS of $-0.94, surpassing analyst estimates by $0.26, and revenue of $10.18M, which also topped the consensus estimate. Despite the strong earnings beat, the company's stock price has seen declines over the last three and twelve months. InvestingPro assesses …

Jack Sinclair (SFM) plans to sell 21,576 shares of common stock via broker

Jack Sinclair, an insider at Sprouts Farmers Market (SFM), has filed to sell 21,576 shares of common stock through Goldman Sachs & Co. LLC, with an aggregate market value of over $1.9 million. These shares were acquired as compensation via stock options on March …

Crispr Therapeutics AG (CRSP) rebounds 3.1% before Aug. 3 earnings, but trend stays inactive

The gene-editing biotech reports with medium-term performance still under pressure and volume running below its 13-week average.

CRISPR Therapeutics (NASDAQ:CRSP) Announces Quarterly Earnings Results, Beats Estimates By $0.26 EPS

CRISPR Therapeutics (NASDAQ:CRSP) announced its quarterly earnings, reporting an adjusted loss of $0.94 per share, significantly beating analyst estimates of a $1.20 loss. The company also surpassed revenue expectations, bringing in $10.18 million against an estimated $7.45 million. Following these results, CRSP shares rose …

Earnings Flash (CRSP) CRISPR Therapeutics AG Reports Q2 Revenue $10.2M, vs. FactSet Est of $7.4M

CRISPR Therapeutics AG (CRSP) reported Q2 revenue of $10.2 million, significantly surpassing the FactSet estimate of $7.4 million. This earnings flash highlights the company's financial performance for the second quarter and six months ended June 30, 2026. The article also mentions the company's recent …

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026. "The second quarter reflected strong execution across CRISPR Therapeutics' portfolio and platform," said Samarth Kulkarni, Ph.D., Chairman and …

CRISPR Therapeutics reports $91.2 million second quarter net loss

CRISPR Therapeutics (CRSP) reported a net loss of $91.2 million for the second quarter of 2026, a significant improvement from the $208.5 million loss in the same period last year, while total revenue increased to $10.2 million. The company's gene-editing therapy, CASGEVY, generated $76 …

CRISPR Therapeutics AG (CRSP) Reports Q2 Loss of $0.94 per Share

CRISPR Therapeutics AG (CRSP) reported a Q2 loss of $0.94 per share on revenue of $10.18 million, missing analyst revenue estimates but exceeding them on earnings per share. The company saw significant growth in revenue from its lead drug, CASGEVY, with a 151% year-over-year …

Sprout Social (SPT) Climbs 2.5% to $8.79, Holding Above Key Support - Reversal Trade

Tamil Nadu Newsprint and Papers Share Price Outlook: Where It Could Be in 3 Years

Sprott Inc. $SII Shares Bought by Sapient Capital LLC

Does BrightSpring (BTSG) Upgraded 2026 Revenue Outlook Reinforce or Stretch Its Long-Term Growth Narrative?

CRISPR Therapeutics (CRSP) Expected to Release Earnings on Monday

CRISPR Therapeutics (CRSP) is anticipated to release its Q2 2026 earnings on Monday, August 10th, with analysts forecasting a loss of $1.20 per share and revenue of $7.45 million. The company's shares are currently trading near their 52-week low, and it remains unprofitable, though …

Why Sprouts Farmers Market Stock Surged This Week

Sprouts Farmers Market (SFM) stock rose over 16% this past week after the natural and organic grocery chain reported stronger-than-expected financial results for its fiscal second quarter. Despite a 1% decline in comparable sales, net sales grew 5% year over year to $2.3 billion, …

Henshaw Capital LLC Buys Shares of 12,307 Sprouts Farmers Market, Inc. $SFM

Henshaw Capital LLC acquired 12,307 shares of Sprouts Farmers Market, Inc. (NASDAQ:SFM) in Q1 2026, valued at approximately $949,000. This comes as Sprouts Farmers Market exceeded second-quarter earnings expectations, with adjusted EPS of $1.37 and revenue of $2.33 billion, a 4.7% year-over-year increase. Despite …

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Spruce Biosciences (NASDAQ:SPRB) has received a "Moderate Buy" consensus recommendation from eleven brokerages, with an average 12-month price target of $162.63. Despite several firms lowering their price targets recently, new coverage from B. Riley and Craig Hallum maintained buy ratings. The company reported a …

Sprott Focus Trust (FUND) Slides 0.8% to $9.92: Key Levels to Watch - AAII Bullish

Spring Valley Acquisition Corp. IV (SVIV) Holds Near $10.21 as Pre-Merger Trading Remains Rangebound - Stock Buy Zone

BrightSpring Health Services (BTSG) Stock Retreats As Valuation Angst Trumps Growth

Bluspring Enterprises posts ₹15.8M loss in Q1FY27 as revenue hits ₹9.49B

Bluspring revenue rises 20% to ₹930 crore in Q1 FY27

Sprouts Farmers Market Number of Employees 2026 | Employee Count & Headcount Data

Sprouts Farmers Market, Inc. (SFM) had approximately 36,031 employees worldwide as of March 2026, marking a 4.5% decline from 37,719 employees in 2023. Despite this reduction in headcount, the company is actively hiring, with 3,087 active job postings in 2026, a 35.6% increase from …

CRISPR Therapeutics (CRSP) Rebounded In Its Latest Session, Is It Still Well Below Fair Value?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. CRISPR Therapeutics Stock Reaction To Recent Trading Session CRISPR Therapeutics (NasdaqGM:CRSP) recently finished a trading session with a positive price move that outpaced the S&P …

Sprouts Farmers Market, Inc. (NASDAQ:SFM) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Sprouts Farmers Market (NASDAQ:SFM) shareholders saw a 16% stock price increase following its second-quarter earnings report, where revenues were in line with forecasts and EPS beat expectations. Despite this, analysts have made no major changes to their 2026 revenue and earnings per share estimates, …

CRSP Stock Price and Chart — NASDAQ:CRSP

This page provides a comprehensive overview of CRISPR Therapeutics AG (CRSP) stock, including its current price, historical performance, key financial statistics, and company details. It also features a collection of recent news and trading ideas from analysts and community members regarding CRSP's stock movement, …

Renaissance Technologies LLC Purchases 19,500 Shares of Sprott Inc. $SII

Renaissance Technologies LLC increased its stake in Sprott Inc. by 23.8% in the first quarter, acquiring an additional 19,500 shares. This brings their total holding to 101,600 shares valued at approximately $14.5 million. Sprott Inc. exceeded its first-quarter earnings expectations, reporting $1.13 EPS against …

Sprinklr, Inc. Class A Revenue Breakdown – DUS:9EI

Sprinklr, Inc. Class A (DUS:9EI) generated 723.44 million EUR last year, with its Subscription segment contributing the most at 638.31 million EUR. The United States was the largest regional contributor, accounting for 372.86 million EUR. This data provides a breakdown of the company's revenue …

Why BrightSpring Health Services (BTSG) Shares Are Trading Lower Today

Why BrightSpring Health Services (BTSG) Shares Are Trading Lower Today What Happened? Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) fell 17.5% in the afternoon session after the company reported strong second-quarter results and increased its full-year guidance, prompting a "sell-the-news" reaction from …

Sprout Social, Inc. Class A Revenue Breakdown – SWB:SPJ

This article provides a financial breakdown of Sprout Social, Inc. Class A (SWB:SPJ), highlighting its revenue performance. The company generated €389.56 million last year, with its Subscription segment being the top performer at €385.70 million. The United States was the largest geographical contributor, accounting …

BrightSpring Stock And 2 Healthcare Picks Tied To Home Based Care Demand

Spruce Power Holding Corporation Revenue Breakdown – NYSE:SPRU

BrightSpring Health Services slides 18% after Q2 results (BTSG:NASDAQ)

BrightSpring Health Services Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Revenue Outlook

BrightSpring Health Services reported an increase in Q2 adjusted earnings and revenue. The company's adjusted EBITDA grew by 17.5% year-over-year to $188 million, while net revenue rose by 14.1% to $2.3 billion. Based on these strong results and acquisition activity, BrightSpring has raised its …

Sprott Inc (SII) Valuation: PE, PB & Fair Value Analysis

Sprott Inc's current valuation score is 5.69, placing it 100th out of 118 in the Investment Banking & Investment Services industry. Its P/E ratio stands at 31.40, which is significantly below its recent high and above its recent low. Other valuation metrics like P/B, …

BrightSpring Health Services Q2 Earnings Call Highlights

This article first appeared on GuruFocus. Release Date: July 31, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BrightSpring Health Services Inc (NASDAQ:BTSG) delivered strong Q2 2026 results with total revenue of $3.9 …